The establishment of epstein‐barr virus nuclear antigen‐positive (SP‐50B) and epstein‐barr virus nuclear antigen‐negative (SP‐53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma